Press release
United States Multi-Plex Immunoassays Market to Reach USD 6.90 Billion by 2033, Driven by High-Throughput Screening and Personalized Medicine Trends | DataM Intelligence
Multi-Plex Immunoassays Market
United States: Recent Industry Developments
✅ In October 2025, Thermo Fisher Scientific launched a new high-throughput multi-plex platform capable of analyzing 100+ biomarkers simultaneously.
✅ In October 2025, The FDA approved a novel multi-plex diagnostic panel for early detection of autoimmune disorders.
✅ In October 2025, A major US research institution developed a multi-plex assay for comprehensive cancer biomarker profiling.
Japan: Recent Industry Developments
✅ In October 2025, Sysmex Corporation introduced an automated multi-plex immunoassay system for clinical laboratory use.
✅ In October 2025, Japan's Ministry of Health approved a multi-plex infectious disease panel for rapid pathogen detection.
✅ In October 2025, A Japanese biotech company developed a novel multi-plex assay for neurodegenerative disease biomarkers.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/multi-plex-immunoassays-market?jd
Market Trends & Drivers
The Multi-Plex Immunoassays Market is experiencing exponential growth driven by the increasing demand for high-throughput screening, advancements in biomarker discovery, and the need for cost-effective diagnostic solutions. Key trends include the integration of artificial intelligence for data analysis, development of point-of-care multi-plex systems, and expansion into personalized medicine applications. The growing prevalence of chronic diseases, rising research and development activities, and technological innovations in detection methods are significantly accelerating market adoption across various sectors.
Competitive Landscape
The market features strong competition among diagnostic companies, life science tools providers, and specialized assay developers.
Thermo Fisher Scientific Inc. leads the market with its Luminex-based multi-plex platforms and extensive assay menu.
Bio-Rad Laboratories, Inc. provides comprehensive multi-plex solutions through its Bio-Plex suspension array systems.
Merck KGaA (MilliporeSigma) offers advanced multi-plex immunoassay kits and reagents for research applications.
Qiagen N.V. develops multi-plex molecular and protein detection systems for diagnostic and research use.
Sysmex Corporation specializes in automated multi-plex systems for clinical diagnostics and laboratory testing.
Danaher Corporation (Beckman Coulter) provides multi-plex immunoassay platforms through its life sciences division.
Abcam plc offers specialized multi-plex assay kits and antibodies for research applications.
Meso Scale Discovery, LLC develops electrochemiluminescence-based multi-plex assay platforms.
Randox Laboratories Ltd. provides multi-plex biochip array technology for clinical diagnostics.
Olink Proteomics AB specializes in high-throughput multi-plex protein biomarker discovery platforms.
Segmentation
By Product Type (Consumables, Kits & Reagents, Instruments & Accessories, Software & Services)
By Technique (Protein Based Multiplex Assays, Nucleic Acid Based Multiplex Assays, Others)
By Application (Clinical Diagnostics, Drug Discovery & Development, Biomarker Discovery, Personalized/Precision Medicine, Others)
By End-User (Pharmaceutical & Biotechnology Companies, Hospitals, Diagnostic Centers, Research Institutes, Others)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/multi-plex-immunoassays-market?jd
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us:
DataM Intelligence is a full-service market research and consulting firm, guiding organizations from initial insight to strategic implementation. We transform proprietary data, emerging trends, and market developments into agile, actionable solutions.
Our robust methodology powers a vast research database featuring 6,300+ syndicated and custom reports across 40+ industries. We have delivered strategic solutions to 200+ companies in 50+ countries, addressing the core research challenges that drive growth for our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Multi-Plex Immunoassays Market to Reach USD 6.90 Billion by 2033, Driven by High-Throughput Screening and Personalized Medicine Trends | DataM Intelligence here
News-ID: 4228863 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Renal Stents Market to Grow at 6.5% During the Forecast 2025-2033, …
The global Renal Stents Market reached USD 1.19 Billion in 2024 and is projected to reach USD 2.08 Billion by 2033, growing at a CAGR of 6.5% during the forecast period 2025-2033, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Boston Scientific received FDA approval for its next-generation drug-eluting renal stent for atherosclerotic renal artery stenosis.
✅ In October 2025, The American College of Cardiology updated…
United States Biologics Market Projected to Expand at 7.1% CAGR, Reaching USD 96 …
The global Biologics Market reached USD 512.25 billion in 2024 and is projected to reach USD 966.98 billion by 2033, growing at a CAGR of 7.1% during the forecast period 2025-2033, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Johnson & Johnson received FDA approval for its novel interleukin inhibitor for treating moderate-to-severe psoriasis.
✅ In October 2025, The Centers for Medicare & Medicaid Services…
Japan Ultrasonic Flow Meter Market Insights: Water Management and Energy Efficie …
Tokyo, Japan, DataM Intelligence: The Japan Ultrasonic Flow Meter Market was valued at USD 0.20 billion in 2024. It is expected to reach USD 0.35 billion by 2033, growing at a rate of 7.4%.
This growth is driven by increasing demand for accurate, non-invasive flow measurement in the oil and gas, water and wastewater, and chemical industries. Clamp-on ultrasonic meters are preferred because they are easy to install, require little…
Energy Management Systems Market Growth Forecast 2024 to 2031 Driven by Smart In …
The Global Energy Management Systems (EMS) Market is projected to grow remarkably from USD 53.2 billion in 2024 to around USD 111.8 billion by 2032, registering a robust CAGR of 10.1% during the forecast period. This growth reflects the global shift toward energy efficiency, smart building technologies, and carbon-neutral operations across industries.
Driven by the integration of IoT, AI, and cloud analytics, along with stringent government regulations for emission reduction, the…
More Releases for Immunoassays
Multiplex Detection Immunoassays Market to Witness Growth Acceleration by 2030
The latest research study released by Transparency Market Research on "Multiplex Detection Immunoassays Market Forecast to 2020-2030 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Multiplex Detection Immunoassays industry, as…
Multiplex Detection Immunoassays Market Interpreted by a New Report
Multiplex Detection Immunoassays Market: Introduction
According to the report, the global multiplex detection immunoassays market was valued at US$ 1.5 Bn in 2019 and is projected to expand at a CAGR of 7.5% from 2020 to 2030. Multiplex immunoassays provide sufficient analytical performance to evaluate serum biomarkers that complement each other in the detection of a larger number of patient samples. The use of differentially detectable beads of different regions enables simultaneous identification and quantification of multiple…
Immunoassays Market Growth Prospects, Trends and Forecast up to 2030
The most recent report published by Market Research Inc. indicates that the Immunoassays Market is likely to accelerate significantly in the next few years. Specialists have studied market drivers, restraints, risks and prospects in the global market. The Immunoassays Market report shows the likely direction of the market in the coming years along with its assessments. A meticulous study purposes to understand the market price. By analyzing the competitive landscape,…
Immunoassays Market Key Opportunities, Strategic Assessment Forecast To 2022
Precision Business Insights published a research report on research report “Immunoassays Market: By Product & Service (Reagents and Kits, Analyzers, Software), Technology (ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, PCR), By Application (Infectious Diseases, Oncology, Cardiology, Endocrinology, Hematology), End User (Hospitals, Diagnostic centers, Blood Banks, Others) By Geography- Global/Region/Country Forecast to 2028”. The global immunoassays market is anticipated to grow at USD 39.2 billion till 2027 from USD…
Enzyme Immunoassay (EIA) Reagents and Devices Market 2018-2025| (Enzyme Immunoas …
Global Enzyme Immunoassay (EIA) Reagents and Devices Market Research Report Brief Focus On Study About Enzyme Immunoassay (EIA) Reagents and Devices Market, Which Provides Industry volume, Market Revenue, Market Segments , Market Trends, Growth aspects A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report such as:
Enzyme Immunoassay (EIA) Reagents and Devices Technology :-Enzyme Immunoassays, Fluorescent Immunoassays, Chemiluminescence Immunoassays, Radioimmunoassay, and…
Asia-Pacific Immunoassays Market - Key Trends and Opportunities to 2021
According to the report “Asia-Pacific Immunoassays Market,” published by Market Data Forecast, the global market is projected to reach USD 5.32 billion by 2021 from USD 3.29 billion in 2016, at a CAGR of 10.12% from 2016 to 2021.
Immunoassays are bio analytical methods in which the quantisation of the analyte depends on the reaction of an antigen (analyte) and an antibody. Immunoassays have been widely used in many important areas…
